All news

ResMed CEO sells

Alpha Vantage · Investing.com · · AI-summarised by FinFlash

ResMed (NYSE: RMD) Chairman and CEO Michael Farrell sold 4,991 shares of the company's common stock for over

Read original source

RMD company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.